(19)
(11) EP 1 828 168 A2

(12)

(88) Date of publication A3:
21.09.2006

(43) Date of publication:
05.09.2007 Bulletin 2007/36

(21) Application number: 05817509.2

(22) Date of filing: 06.12.2005
(51) International Patent Classification (IPC): 
C07D 401/14(2006.01)
(86) International application number:
PCT/EP2005/056501
(87) International publication number:
WO 2006/061373 (15.06.2006 Gazette 2006/24)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 07.12.2004 EP 04106351
07.12.2004 US 633439 P

(71) Applicant: Solvay Pharmaceuticals B.V.
1381 CP Weesp (NL)

(72) Inventors:
  • VAN HES, Roelof c/o Solvay Pharmaceuticals B.V.
    NL-1381 CP Weesp (NL)
  • SMID, Pieter c/o Solvay Pharmaceuticals B.V.
    NL-1381 CP Weesp (NL)
  • KRUSE, Cornelis G. c/o Solvay Pharmaceuticals B.V.
    NL-1381 C P Weesp (NL)
  • TULP, Martinus T. M. c/o Solvay Pharmaceuticals BV
    NL-1381 CP Weesp (NL)

(74) Representative: Hogenbirk, Marijke et al
Octrooibureau Zoan B.V. P.O. Box 140
NL-1380 AC Weesp
NL-1380 AC Weesp (NL)

   


(54) TETRAHYDROPYRIDIN-4-YL INDOLES WITH A COMBINATION OF AFFINITY FOR DOPAMINE-D2 RECEPTORS AND SEROTONIN REUPTAKE SITES